about
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityRapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaksEnvironment Control to Improve Recombinant Protein Yields in Plants Based on Agrobacterium-Mediated Transient Gene ExpressionBulk production of the antiviral lectin griffithsinInvestigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidateBiochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1.N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.Cholera toxin B: one subunit with many pharmaceutical applications.Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Scalable Production of HPV16 L1 Protein and VLPs from Tobacco LeavesEfficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesTranscytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes.Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?Effect of temperature post viral vector inoculation on the amount of hemagglutinin transiently expressed in Nicotiana benthamiana leaves.Effects of plant density on recombinant hemagglutinin yields in an Agrobacterium-mediated transient gene expression system using Nicotiana benthamiana plants.Removal of bacterial suspension water occupying the intercellular space of detached leaves after agroinfiltration improves the yield of recombinant hemagglutinin in a Nicotiana benthamiana transient gene expression system.Production of Recombinant Cholera Toxin B Subunit in Nicotiana benthamiana Using GENEWARE® Tobacco Mosaic Virus Vector.Design and production of genetically modified soybean protein with anti-hypertensive activity by incorporating potent analogue of ovokinin(2-7).P12-16. Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB-MPR.P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1.Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa.Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression.Facile Method for the Production of Recombinant Cholera Toxin B Subunit in E. coli.Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates.Bioactive peptides derived from food proteins preventing lifestyle-related diseasesDesigning potent derivatives of ovokinin(2-7), an anti-hypertensive peptide derived from ovalbuminDesign of a highly potent anti-hypertensive peptide based on ovokinin(2-7)A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric arteryDesign of a genetically modified soybean protein preventing hypertension based on an anti-hypertensive peptide derived from ovalbuminOral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colonCo-expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plantsMetastasis of cholangiocarcinoma is promoted by extended high-mannose glycansA novel anti-HIV-1 bispecific bNAb-lectin fusion protein engineered in a plant-based transient expression systemRepeated Oral Administration of a KDEL-tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis Despite a Robust Immunogenic ResponseCancer biologics made in plants
P50
Q21076115-DED9F8E1-0981-4908-BDD5-F56574F60D99Q21090119-7627C560-82C1-490B-8457-2FA29B945A2EQ26750828-CCD54F10-E51A-4AC8-8494-3ABF38C7D2E8Q26801491-5C1F2311-EF7D-44A4-98D1-D8E60BFC4F19Q28741890-9371F64F-6BE0-4FE7-9E2A-345AF4047FE9Q30373529-DAD6AB6E-328A-452E-A413-B6867DB35A3BQ34242643-DFAEF8E2-64E6-4792-945B-C41393620832Q35003962-661B485E-608A-4465-9F12-B16241EC7EE4Q35232735-7A5B6822-363E-4031-AEC7-5CAEC7F049EFQ35960908-3EE07EDF-6CB3-449B-B76E-55AF3A1ABDC3Q36102960-D28C15B5-6230-4B4A-9C1F-BEE139A23489Q36785795-98C927F6-5793-4A8A-859F-3EC77BC93A90Q37348636-03ACBFB5-74EE-48DC-81EF-449C04DA525FQ37358616-8E5BA302-CE7B-4527-BDB5-6660383F887AQ37535105-35928F15-7B35-47BB-9F99-0CAD70B3147AQ40113286-E3A7F010-86AF-4F7A-AD6E-62D8EC8C8546Q40143890-153B3BDD-B186-4525-AC59-996F1B6AB96BQ40219981-BB91A2EC-A712-44A1-A2C8-AFBCE4DDA7F3Q40261619-377BD47C-C074-4DAD-9646-A3B3926891AAQ40438356-1DC7364B-F6E2-4A7D-B267-0B039528AB77Q40891906-F01627CF-C2FE-408C-929F-B2EC1165C300Q43619815-44EC516D-ABF0-49E5-A19B-2B2D1B7A9A86Q45851574-2660BA23-07CC-4770-BC8C-6543042DACF9Q46730264-FE02C243-7B25-42D5-9ECB-B858870BA05BQ47105986-53B819A8-D132-402F-9967-8C171E4DDD47Q49470037-3AAB83EC-FD75-41FB-901C-D2E9AC347887Q51372206-D146B2FB-C71C-4F90-9719-47BD355BEFE0Q53002224-4431A7AF-55F5-47E7-A234-15E6B8D5FDFEQ55214924-D7B24106-4A27-4A88-854A-5ABE998C6A65Q73535260-F800CEDC-268E-41E5-98CA-26D59EFF7F31Q73823811-6C146648-3F7E-4DE6-B61E-D1B7247A0199Q74576262-7AC104A5-099A-4815-8E6A-5392ED4FF1D1Q77936263-17EDFDCC-4C86-4266-AB9A-CA72FA637FDBQ80473119-CED91C32-BC10-4AD6-83F2-2C64A8CC7685Q88672906-C2CF6B81-8B38-4A63-A001-E208C5672B99Q89872369-18A48F5B-395B-487F-B1C8-6AF616C679AEQ90660454-6FE8E790-EFAA-41C0-BD24-11BB838397BEQ91392593-D6D898FA-9535-4DF9-9D22-C5FA6FC2A467Q91399812-ABACDA8E-A86E-4A04-8294-F062D0F5010AQ91566493-F4CC681D-E7BC-4898-85E7-D918D7FEB284
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nobuyuki Matoba
@ast
Nobuyuki Matoba
@en
Nobuyuki Matoba
@es
Nobuyuki Matoba
@nl
type
label
Nobuyuki Matoba
@ast
Nobuyuki Matoba
@en
Nobuyuki Matoba
@es
Nobuyuki Matoba
@nl
prefLabel
Nobuyuki Matoba
@ast
Nobuyuki Matoba
@en
Nobuyuki Matoba
@es
Nobuyuki Matoba
@nl
P106
P1153
36848263100
P31
P496
0000-0001-7231-3004